Cited by 275Mitochondrial Function and PathologyAlzheimer's disease research and treatmentsCoenzyme Q10 studies and effects

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Cybrids in Alzheimer's disease: A cellular model of the disease?

Swerdlow, R. H., Parks, J. K., Cassarino, D. S., Maguire, D. J., Maguire, R. S., Bennett, J. P., Davis, Robert E., Parker, W. D.·1997·Neurology

DOI 10.1212/wnl.49.4.918

Open this paper in CoChat — free account

Abstract

The mitochondrial electron transport chain enzyme cytochrome c oxidase (COX) is defective in patients with sporadic Alzheimer's disease (AD). This defect arises from the mutation of mitochondrial DNA (mtDNA). To develop a tissue culture system that would express this genetically derived bioenergetic lesion and permit characterization of its functional consequences, we depleted Ntera2/D1 (NT2) teratocarcinoma cells of endogenous mtDNA and repopulated them with platelet mtDNA from AD patients. Cytochrome c oxidase activity was depressed in the resulting AD cytoplasmic hybrids (cybrids) compared with cybrids prepared with mtDNA from non-AD controls. Reactive oxygen species (ROS) production and free radical scavenging enzyme activities were significantly elevated in AD cybrids. A COX defect in NT2 AD cybrid lines indicates that AD patients possess mtDNA COX gene mutations that are sufficient for determining this biochemical lesion. Expression of unique functional characteristics (increased ROS production and free radical scavenging enzyme activities) relevant to neurodegeneration demonstrates the utility of these cells in defining AD pathophysiology at a cellular level. This in vitro tissue culture model of AD may prove useful in drug screening.

Integrity signals

Registry

Crossref · 10.1212/wnl.49.4.918

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The insulin signaling system.
White, M. F., & Kahn, C. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42297-6 · Cited by 1,707
The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity
Hansen, L., Salmon, D., Galasko, D., Masliah, E., Katzman, R., DeTeresa, R., Thal, L., Pay, M. M., Hofstetter, R., Klauber, M., et al. (1990) · Neurology · doi:10.1212/wnl.40.1.1 · Cited by 1,068
Origin and functional consequences of the complex I defect in Parkinson's disease
Swerdlow, R. H., Parks, J. K., Miller, S. W., Davis, R. E., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., Bennett, J. P., & Parker, W. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400417 · Cited by 638
Self-citation
Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease
Mutisya, E. M., Bowling, A. C., & Beal, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062179.x · Cited by 531
Megadose corticosteroids in multiple sclerosis
Kupersmith, M. J., Kaufman, D., Paty, D. W., Ebers, G. C., McFarland, H., Johnson, K., Reingold, S. C., & Whitaker, J. N. (1994) · Neurology · doi:10.1212/wnl.44.1.1 · Cited by 386
Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line.
Younkin, D. P., Tang, C. M., Hardy, M., Reddy, U. R., Shi, Q. Y., Pleasure, S. J., Lee, V. M., & Pleasure, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2174 · Cited by 178
Chemokine Receptors and HIV-1: An Attractive Pair?
Bates, P. F. (1996) · Cell · doi:10.1016/s0092-8674(00)80070-7 · Cited by 147
gp130, a Shared Signal Transducing Receptor Component for Hematopoietic and Neuropoietic Cytokines
Taga, T. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010001.x · Cited by 135
Cytochrome Oxidase Inhibition: A Novel Animal Model of Alzheimer's Disease
Bennett, M. C., Diamond, D. M., Stryker, S. L., Parks, J. K., & Parker, W. D. (1992) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/002383099200500206 · Cited by 77
Self-citation

Flagged first, then by citations

Show all 18 references

Research works printed but not linked: 22

Katzman R. Alzheimer's disease. N Engl J Med 1986;314:964-973.
Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995;38:357-366.
Greenlund LJS, Deckwerth TL, Johnson EM. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed cell death. Neuron 1995;14:303-315.
10.1212/WNL.44.1.1 · DOI
Lakis J, Glasco S, Miller SW, Thal LJ, Davis RE. Production of reactive oxygen species correlates with decreased cytochrome oxidase activity in Alzheimer's disease cybrids [abstract]. Soc Neurosci Abst 1995;21:979.
Davis RE, Miller S, Hernstadt C, et al. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1997;94:4564-4569.
Chomyn A, Lai ST, Shakeley R, Bresolin N, Scarlatto G, Attardi G. Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals-and complementation behavior of tRNAlys mutation causing myoclonic epilepsy and ragged red fibers. J Hum Genet 1994;54:966-974.
Swerdlow RH, Parks JK, Miller SW, Pattee G, Davis RE, Parker WD. Evidence of genetic mitochondrial pathology in sporadic amyotrophic lateral sclerosis [abstract]. Soc Neurosci Abstr 1996;22:2143.
Glasco S, Miller SW, Thal LJ, Davis RE. Alzheimer's disease cybrids manifest a cytochrome oxidase defect [abstract]. Soc Neurosci Abstr 1995;21:979.
Pleasure SJ, Lee VM. Ntera 2 cells: a human cell line with characteristics expected of a human committed neuronal progenitor cell. J Neurosci Res 1993;35:585-602.
Wertkin AM, Turner RS, Pleasure SJ, et al. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular β-amyloid or A4 peptides. Proc Natl Acad Sci USA 1993;90:9513-9517.
McKhann G, Drachmann D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease. Neurology 1984;34:939-944.
Rosenkranz AR, Schmaldienst S, Stuhlmeier KM, Chen W, Knapp W, Zlabinger GJ. A microplate assay for the detection of oxidative products using 2′,7′-dichlorofluorescein-diacetate. J Immunol Methods 1992;156:39-45.
Herweijer H, Stokdijk W, Visser JWM. High-speed photodamaged cell selection using bromodeoxyuridine/Hoechst 33342 photosensitized cell killing. Cytometry 1988;9:143-149.
Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985;113:484-490.
Carmagnol F, Sinet PM, Jerome H. Selenium-dependent and non-selenium dependent glutathione peroxidases in human tissue culture extracts. Biochim Biophys Acta 1983;759:49-57.
Wiseman A, Attardi G. Reversible tenfold reduction in mitochondria DNA content of human cells treated with ethidium bromide. Mol Gen Genet 1978;167:51-63.
Desjardins P, Frost E, Morais R. Ethidium bromide-induced loss of mitochondrial DNA from primary chicken embryo fibroblasts. Mol Cell Biol 1985;5:1163-1169.
Morais R, Desjardins P, Turmel C, Zinkewich-Peotti K. Development of continuous avian cell lines depleted of mitochondrial DNA. In Vitro Cell Dev Biol 1988;24:649-658.
Gregoire M, Morais R, Quilliam MA, Gravel D. On auxotrophy for pyrimidines of respiration-deficient chick embryo cells. Eur J Biochem 1984;142:49-55.
King MP, Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 1989;246:500-503.
Martinus RD, Linnane AW, Nagley P. Growth ofρ0 human namalwa cells lacking oxidative phosphorylation can be sustained by redox compounds potassium ferricyanide or coenzyme Q10 putatively acting through the plasma membrane oxidase. Biochem Mol Biol Int 1993;31:997-1005.

Sorted by citations

Items 201–275 of 275

May “Mitochondrial Eve” and Mitochondrial Haplogroups Play a Role in Neurodegeneration and Alzheimer′s Disease?
Ienco, E. C., Simoncini, C., Orsucci, D., Petrucci, L., Filosto, M., Mancuso, M., & Siciliano, G. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/709061 · Cited by 26
Long‐term A β exposure augments m C a2+‐independent m ROS ‐mediated depletion of cardiolipin for the shift of a lethal transient mitochondrial permeability transition to its permanent mode in NARP cybrids: a protective targeting of melatonin
Hsiao, C., Peng, T., Peng, A. C., Reiter, R. J., Tanaka, M., Lai, Y., & Jou, M. (2012) · Journal of Pineal Research · doi:10.1111/jpi.12004 · Cited by 24
Is there a primary role of the mitochondrial genome in Alzheimer’s disease?
Mancuso, M., Calsolaro, V., Orsucci, D., Siciliano, G., & Murri, L. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9239-1 · Cited by 24
Two point mutations in mitochondrial DNA of cytochrome c oxidase coexist with normal mtDNA in a patient with Alzheimer’s disease
Qiu, X., Chen, Y., & Zhou, M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03190-5 · Cited by 24
Bioenergetic and inflammatory systemic phenotypes in Alzheimer’s disease APOE ε4‐carriers
Wilkins, H., Wang, X., Menta, B. W., Koppel, S. J., Bothwell, R. J., Becker, A. M., Anderson, H., Schwartz, E., Pei, D., Yellapu, N. K., et al. (2021) · Aging Cell · doi:10.1111/acel.13356 · Cited by 23
Self-citation
Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer’s Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes
Kim, S. H., Choi, K. Y., Park, Y., McLean, C., Park, J., Lee, J. H., Lee, K., Kim, B. C., Huh, Y. H., Lee, K. H., et al. (2021) · Cells · doi:10.3390/cells10102697 · Cited by 23
Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer’s Disease
Adiele, R. C., & Adiele, C. A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150967 · Cited by 23
The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease
Moreira, P. I., Zhu, X., Lee, H., Honda, K., Smith, M. A., & Perry, G. L. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.01.024 · Cited by 22
Molecular characterization of mtDNA depleted and repleted NT2 cell lines
Binder, D. R., Dunn, W. H., & Swerdlow, R. H. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.04.003 · Cited by 20
Self-citation
Poly(ADP-ribosylation) and neurodegenerative disorders
Basello, D. A., & Scovassi, A. I. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.07.005 · Cited by 19
Genetic algorithm for analysis of mutations in Parkinson's disease
Smigrodzki, R. M., Goertzel, B., Pennachin, C. L., Coelho, L. D. S., Prosdocimi, F., & Parker, W. D. (2005) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2004.11.006 · Cited by 19
Self-citation
The Rationale for Insulin Therapy in Alzheimer’s Disease
Ribarič, S. (2016) · Molecules · doi:10.3390/molecules21060689 · Cited by 20
Alterations in muscarinic receptor-coupled phosphoinositide hydrolysis and AP-1 activation in Alzheimer’s disease cybrid cells☆
Sarno, P. D., Bijur, G. N., Lü, R., Davis, R. E., & Jope, R. S. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00095-6 · Cited by 18
Self-citation
The Key Role of Oxidative Stress in Alzheimer's Disease
Moreira, P. I., Nunomura, A., Honda, K., Aliev, G. M., Casadesús, G., Zhu, X., Smith, M. A., & Perry, G. L. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50153-8 · Cited by 18
Transmitochondrial technology in animal cells
Moraes, C. T., Dey, R., & Barrientos, A. (2001) · Methods in cell biology · doi:10.1016/s0091-679x(01)65023-4 · Cited by 18
Modification of endoplasmic reticulum Ca2+ stores by select oxidants produces changes reminiscent of those in cells from patients with Alzheimer disease
Huang, H., Chen, H., Xu, H., & Gibson, G. E. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.05.017 · Cited by 18
Chronic Mitochondrial Inhibition Induces Glutamate-Mediated Corticomotoneuron Death in an Organotypic Culture Model
van Westerlaak, M. G. H., Joosten, E. A. J., Gribnau, A. A. M., Cools, A. R., & Bär, P. R. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7570 · Cited by 18
Involvement of mitochondria in Alzheimer’s disease pathogenesis and their potential as targets for phytotherapeutics
Maruthiyodan, S., Mumbrekar, K. D., & Guruprasad, K. P. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101868 · Cited by 18
Mitochondrial Dysfunction Enhances Susceptibility to Oxidative Stress by Down-Regulation of Thioredoxin in Human Neuroblastoma Cells
Ding, H., Gao, J., Zhu, Z., Xiong, Y., & Liu, J. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9405-y · Cited by 17
Pharmacologic enrichment of exosome yields and mitochondrial cargo
Wang, X., Berkowicz, A., King, K., Menta, B. W., Gabrielli, A. P., Novikova, L., Troutwine, B., Pleen, J., Wilkins, H., & Swerdlow, R. H. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.04.001 · Cited by 16
Self-citation
Mitochondria Profoundly Influence Apolipoprotein E Biology
Gabrielli, A. P., Weidling, I. W., Ranjan, A., Wang, X., Novikova, L., Chowdhury, S. R., Menta, B. W., Berkowicz, A., Wilkins, H., Peterson, K. R., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221177 · Cited by 16
Self-citation
Could Amyloid-β 1–42 or α-Synuclein Interact Directly with Mitochondrial DNA? A Hypothesis
Gezen‐Ak, D., Yurttaş, Z., Çamoğlu, T., & Dursun, E. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00512 · Cited by 15
Cybrid technology
Bacman, S. R., Nissanka, N., & Moraes, C. T. (2019) · Methods in cell biology · doi:10.1016/bs.mcb.2019.11.025 · Cited by 15
Differential display reveals deteriorated mRNA levels of NADH3 (complex I) in cerebellum of patients with Down Syndrome
Krapfenbauer, K., Yoo, B. C., Cairns, N. J., & Lübec, G. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_13 · Cited by 17
Postmortem Alzheimer's Disease Hippocampi Show Oxidative Phosphorylation Gene Expression Opposite that of Isolated Pyramidal Neurons
Rice, A. C., Ladd, A. C., & Bennett, J. P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142937 · Cited by 13
Self-citation
Mitochondrial respiratory chain in brain homogenates: activities in different brain areas in patients with Alzheimer’s disease
Casademont, J., Rodríguez‐Santiago, B., Miró, Ò., Beato, A., López, S., Nunes, V., & Cardellach, F. (2005) · Aging Clinical and Experimental Research · doi:10.1007/bf03337713 · Cited by 14
Mitochondrial dysfunction in diabetes mellitus
Anderson, C. M. (1999) · Drug Development Research · doi:10.1002/(sici)1098-2299(199901)46:1 · Cited by 18
Self-citation
Mitochondrial DNA in somatic cells: A promising target of routine clinical tests
Kang, D., & Hamasaki, N. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.04.014 · Cited by 13
Blood Biomarkers Discriminate Cerebral Amyloid Status and Cognitive Diagnosis when Collected with ACD-A Anticoagulant
Green, Z. D., Kueck, P. J., John, C. S., Burns, J. M., & Morris, J. K. (2023) · Current Alzheimer Research · doi:10.2174/0115672050271523231111192725 · Cited by 11
Neuroprotective mechanism of trans,trans-Farnesol in an ICV-STZ-induced rat model of Alzheimer’s pathology
Kadian, M., Saini, N., Khera, A., & Kumar, A. (2024) · Inflammopharmacology · doi:10.1007/s10787-023-01413-8 · Cited by 12
Quantitative Cytochrome Oxidase Histochemistry: Applications in Human Alzheimer's Disease and Animal Models
Valla, J., Schneider, L. E., Small, A. M., & Gonzalez-Lima, F. (2007) · Journal of Histotechnology · doi:10.1179/his.2007.30.4.235 · Cited by 11
Mitochondria and Alzheimer’s: Is PTCD1 the Smoking Gun?
Pa, J., Andrews, S. J., & Swerdlow, R. H. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.08.003 · Cited by 12
Self-citation
Calpain-mediated MPP+ toxicity in mitochondrial DNA depleted cells
Domingues, A. F., Esteves, A. R., Swerdlow, R. H., Oliveira, C. R., & Cardoso, S. M. (2008) · Neurotoxicity Research · doi:10.1007/bf03033365 · Cited by 12
Self-citation
Prospects for redox-based therapy in neurodegenerative diseases
Friedlich, A. L., & Beal, M. F. (2000) · Neurotoxicity Research · doi:10.1007/bf03033796 · Cited by 12
Unraveling the mystery of citrate transporters in Alzheimer’s disease: An updated review
Mukherjee, A. G., Mishra, S., Gopalakrishnan, A. V., Kannampuzha, S., Murali, R., Wanjari, U. R., Stany, B. K., Vellingiri, B., Madhyastha, H., Deepankumar, K., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102726 · Cited by 11
Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease
Kemna, R. E., Kueck, P. J., Honea, R. A., Clark, Z., Rekowski, M. J., Weidling, I. W., Mayfield, H. D., John, C. S., Burns, J. M., Wilkins, H., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70390 · Cited by 11
Self-citation
Mutations in the Amyloid-β Protein Precursor Reduce Mitochondrial Function and Alter Gene Expression Independent of 42-Residue Amyloid-β Peptide
Pope, C. A., Wilkins, H., Swerdlow, R. H., & Wolfe, M. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210366 · Cited by 8
Self-citation
Mitochondrial Signaling and Neurodegeneration
Picard, M. A., & McManus, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-28637-2_5 · Cited by 11
Mitochondrial DNA depletion analysis by pseudogene ratioing
Swerdlow, R. H., Redpath, G. T., Binder, D. R., Davis, J. N., & VandenBerg, S. R. (2005) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2005.06.023 · Cited by 10
Self-citation
Mitochondria in neurodegeneration
Beal, M. F. (2002) · Springer eBooks · doi:10.1007/978-2-8178-0929-8_3 · Cited by 10
Inhibiting mtDNA transcript translation alters Alzheimer's disease‐associated biology
Gabrielli, A. P., Novikova, L., Ranjan, A., Wang, X., Ernst, N. J., Abeykoon, D., Roberts, A., Kopp, A., Mansel, C. O., Qiao, L., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14275 · Cited by 10
Self-citation
Effects ofβ-amyloid peptide and estrogen on platelet mitochondrial function of Sprague-Dawley rats
Xu, J., Shi, C., Li, Q., Lam, W. P., Wai, M. S. M., & Yew, D. T. W. (2007) · Platelets · doi:10.1080/09537100701206808 · Cited by 9
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
Cardoso, S., Santos, R. X., Correia, S. C., Carvalho, C., Zhu, X., Lee, H., Casadesús, G., Smith, M. A., Perry, G. L., & Moreira, P. I. (2009) · Pharmaceuticals · doi:10.3390/ph2030250 · Cited by 10
Do mitochondrial DNA mutations have a role in neurodegenerative disease?
Krishnan, K. J., Reeve, A. K., & Turnbull, D. M. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351232 · Cited by 9
Neurometabolic disease
Moser, H. W. (1998) · Current Opinion in Neurology · doi:10.1097/00019052-199804000-00002 · Cited by 8
Mitochondrial Medicine: The Central Role of Cellular Energetic Depression and Mitochondria in Cell Pathophysiology
Seppet, E. K., Gizatullina, Z. Z., Trumbeckaitė, S., Zierz, S., Striggow, F., & Gellerich, F. N. (2007) · Wiley eBooks · doi:10.1002/9783527621095.ch15 · Cited by 8
Mitochondrial Medicine
Wallace, D. C., Lott, M. T., & Procaccio, V. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00013-6 · Cited by 8
Mitochondria in Neurodegeneration
Swerdlow, R. H. (2011) · Advances in neurobiology · doi:10.1007/978-1-4614-1788-0_30 · Cited by 7
Self-citation
No evidence of an association between the T16189C mtDNA variant and late onset dementia
GIBSON, A. M., Edwardson, J. A., Turnbull, D. M., McKeith, I. G., Morris, C. M., & Chinnery, P. F. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.010983 · Cited by 6
Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice
Kondak, C., Leith, M., Baddeley, T. C., Santos, R. X., Harrington, C. R., Wischik, C. M., Riedel, G., & Klein, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310810 · Cited by 5
Elevated caspase 3 activity and cytosolic cytochrome c in NT2 cybrids containing amyotrophic lateral sclerosis subject mtDNA
Shrivastava, M., & Subbiah, V. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1074902 · Cited by 5
The Ageing Brain, Mitochondria and Neurodegeneration
Hudson, G. (2016) · Springer eBooks · doi:10.1007/978-3-319-28637-2_3 · Cited by 5
MtDNA‐depleted neuronal cell transcriptomes reveal Alzheimer's disease‐related changes
Menta, B. W., Schueddig, E., Ranjan, A., Li, Y., Andrews, S. J., Wilkins, H., Pei, D., & Swerdlow, R. H. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70929 · Cited by 4
Self-citation
Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets
Sharma, Y., Gupta, J. K., Babu, M. A., Singh, S., & Sindhu, R. K. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02269-5 · Cited by 6
Inorganic Polyphosphate, Mitochondria, and Neurodegeneration
Urquiza, P., & Solesio, M. E. (2022) · Progress in molecular and subcellular biology · doi:10.1007/978-3-031-01237-2_3 · Cited by 4
The Aβcentric Pathway of Alzheimer’s Disease
Villemagne, V. L., Cappai, R., Barnham, K. J., Cherny, R. A., Opazo, C., Novakovic, K. E., Rowe, C. C., & Masters, C. L. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_2 · Cited by 4
Mitochondrial Disease: Maintenance of Mitochondrial Genome and Molecular Diagnostics
Kang, D., & Hamasaki, N. (2006) · Advances in clinical chemistry · doi:10.1016/s0065-2423(06)42006-0 · Cited by 4
The multifaceted role of mitochondrial dysfunction in Alzheimer’s disease pathogenesis
Ebrahimi, R., Mohammadi, I., Ghafourian, K., Firouzabadi, S. R., Saleh, M., Davoody, S., Azad, G., & Esmaeilpour, K. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01850-8 · Cited by 4
Mitochondrial Dysfunction and Alzheimer’s Disease
Ghosh, S. S., Miller, S. W., Herrnstadt, C., Fahy, E., Shinobu, L. A., Galasko, D., Thal, L. J., Beal, M. F., Howell, N., Parker, W. D., et al. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_10 · Cited by 3
Self-citation
Mitochondrial Function and Neurodegenerative Diseases
Wilkins, H. M., Weidling, I., Koppel, S., Wang, X., von Schulze, A., & Swerdlow, R. H. (2018) · The Molecular and Cellular Basis of Neurodegenerative Diseases · doi:10.1016/b978-0-12-811304-2.00013-4 · Cited by 2
Self-citation
ROS-dependent localization of glycolytic enzymes to mitochondria
Esparza‐Moltó, P. B., Goswami, A. V., Bozkurt, S., Münch, C., Newman, L. E., Moyzis, A. G., Rojas, G. R., Guan, D., Jones, J. R., Gage, F. H., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103812 · Cited by 3
Genetik der Alzheimer Demenz
Heun, R., & Papassotiropoulos, A. (1999) · Springer eBooks · doi:10.1007/978-3-642-60228-3_3 · Cited by 2
Amyloid-β protein precursor modulates mitophagy and mitochondrial function through its cellular localization
Strope, T. A., Troutwine, B., Hauger, B. M., Smith, K. P., Swerdlow, R. H., & Wilkins, H. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251360243 · Cited by 2
Self-citation
Mitochondrial Dysfunction and Neurodegenerative Diseases
Lin, M., & Beal, M. F. (1998) · Springer eBooks · doi:10.1007/978-3-662-12509-0_13 · Cited by 1
Mitochondrial Manipulation as a Treatment for Aging
Smigrodzki, R. M., & Portell, F. R. (2010) · Springer eBooks · doi:10.1007/978-90-481-3999-6_16 · Cited by 1
Mitochondrial impact on nerve growth factor production in vascular smooth muscle-derived cells
Sherer, T., Neff, P. S., Parks, J. K., & Tuttle, J. B. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00194-4
Self-citation
mtDNA Mutations in Brain Aging and Neurodegeneration
Krishnan, K. J., & Reeve, A. K. (2011) · Springer eBooks · doi:10.1007/978-0-85729-701-3_5
Mitochondria, metabolic inhibitors and neurodegeneration
Greene, J. G., & Greenamyre, J. T. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.004
Neurodegenerative Disorders Progression
Kaur, R., Kaur, H., Rajput, R., Kumar, S., Rachana, R., & Singh, M. (2018) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-5282-6.ch006
Alzheimer's Disease: A Complex Paradigm
Avramopoulos, D. (2007) · Medical psychiatry · doi:10.3109/9781420019544.001
Mitochondrial Dysfunction and Their Management by Antioxidants
Koteeswaran, K., & Keerthana, N. (2022) · Asian Plant Research Journal · doi:10.9734/aprj/2022/v9i430215
Nanoparticles that target nonamyloid and nontau pathways in Alzheimer’s disease
Alavian, F., & Hajimohammadi, A. (2026) · Discover Nano · doi:10.1186/s11671-026-04747-8 · Cited by 1
Brain Hypometabolism, Oxidative Stress, Maternal Transmission, and Risk of Late-Onset Alzheimer’s Disease
Mosconi, L., Murray, J., McHugh, P. F., & de Leon, M. J. (2013) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-62703-598-9_10
Untitled work
Khan (2000) · doi:10.1002/1531-8249(200008)48:2
Self-citation
Untitled work
(2000) · doi:10.1002/1097-4547(20000915)61:6
Self-citation

Authors: Swerdlow, R. H., Parks, J. K., Cassarino, D. S., Maguire, D. J., Maguire, R. S., Bennett, J. P., Davis, R. E., & Parker, W. D.
Affiliations: Griffith University (AU)
ORCID: Swerdlow, R. H.
Cassarino, D. S.
Bennett, J. P.
Davis, Robert E.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1997-10
Volume: 49
Issue: 4
Pages: 918-925
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.49.4.918
OpenAlex: W4320578147
Cited by: 272
References: 18
Citations by year: 2026: 2 · 2025: 5 · 2024: 4 · 2023: 11 · 2022: 8 · 2021: 7 · 2020: 7 · 2019: 9 · 2018: 4 · 2017: 5 · 2016: 6 · 2015: 4 · 2014: 4 · 2013: 12 · 2012: 11
FWCI: 4.71
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5t32ns007199-15)
National Institute of Neurological Disorders and Stroke (NS-07199, NS34325)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
Keywords: Alzheimer's disease, cybrids, cytochrome c oxidase, mitochondrial DNA mutations, mitochondrial electron transport chain, reactive oxygen species, free radical scavenging enzymes, neurodegeneration, drug screening
MeSH terms: Alzheimer Disease, Brain, Electron Transport Complex IV, Cytoplasm, DNA, Mitochondrial, Genetic Techniques, Humans, Hybridization, Genetic, Mutation, Reference Values, Tumor Cells, Cultured, Reactive Oxygen Species, Gene Transfer Techniques, Teratocarcinoma

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cybrids in Alzheimer's disease: A cellular model of the disease?

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks